3Jung MK, Song KC, Kwon AR, et al. Adult height in girls with central precocious puberty treated with gonadotropin-re- leasing hormone agonist with or without growth hormone [J]. Ann Pediatr Endocrinol Metab, 2014, 19 (4) : 214-219.
4Rudolf FO, Kadokawa H. Effects of STX, a novel estrogen membrane receptor agonist, on GnRH- induced luteinizing hormone secretion from cultured bovine anterior pituitary ceils[J].JVetMedSci, 20!4, 76 (12): 1623-1625.
5Ferrero S, Venturini PL, Gillott DJ, et al. Letrozole and norethis-terone acetate versus letrozole and triptorelin in the treatment of endo-metriosis related pain symptoms: a randomized controlled trial. Re-productive Biology and Endocrinology : RB&E, 2011,9:88.
6Chiocca E, Dati E, Baroncelli GI, et al. Central Precocious Puber-ty: Treatment with Triptorelin 11. 25 mg. The Scientific World Jour-nal, 2012,2012:583751.
7Wang W, Li R, Fang T, et al. Endometriosis fertility index scoremaybe more accurate for predicting the outcomes of in vitrofertilisationthan r - AFS classification in women with endometriosis. Reproduc-tive Biology and Endocrinology : RB&E, 2013 ,11:112.
8Ferrero S,Camerini G, Maggiore ULR, et al. Bowel endometriosis:Recent insights and unsolved problems. World Journal of Gastrointes-tinal Surgery, 2011,3(3) :31 -38.
9Gerlinger C, Faustmann T, Hassall JJ, et al. Treatment of endome-triosis in different ethnic populations : a meta - analysis of two clinicaltrials. BMC Women's Health, 2012( 12) :9.
10Mehedintu C,Plotogea M,Ionescu S,et al.Endometriosis still a challenge[J].J Med Life,2014,7(3):349-357.
